🇺🇸 FDA
Patent

US 8399445

Acetylcysteine composition and uses thereof

granted A61KA61K31/195A61K31/197

Quick answer

US patent 8399445 (Acetylcysteine composition and uses thereof) held by Cumberland Pharmaceuticals Inc. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cumberland Pharmaceuticals Inc.
Grant date
Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/195, A61K31/197, A61K31/198, A61K47/02